AI uses CT scans to better assess heart and metabolic risk
Part of Hormones & metabolism clinical trials.
This study tests whether an artificial intelligence tool can use CT scan images to estimate your cardiometabolic risk (your risk related to heart health and body metabolism). It may help doctors identify risk more accurately for people with higher or lower “FatHealth” status.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and are willing to sign informed consent
- You are between 18 and 80 years old (male or female)
- Your BMI is 25 or higher
- You are able to do the “FatHealth” assessment (the study includes both elevated and non-elevated groups)
- You do not have confirmed diabetes that is being treated with pills or insulin
- You understand English (the study requires English)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at medical records of people who had a heart attack or heart failure and also have diabetes or prediabetes. Researchers will use artificial intelligence to find patterns that might help doctors treat these conditions better in the future.
This study is testing an AI tool to improve heart scans in people with obesity who may have hidden heart disease. If you are 45 or older, have a BMI of 30 or higher, and your doctor thinks you might have heart problems, this study could help find them earlier.
This study uses artificial intelligence and smartphone apps to track health and metabolism in overweight or obese Chinese adults. Researchers want to understand how AI can help monitor and improve metabolic health (how your body processes food and energy).
This study uses artificial intelligence to analyze your heart CT scan and better predict your risk of coronary artery disease (narrowing of the arteries that supply your heart). The goal is to help doctors identify who might need earlier treatment or more careful monitoring.
This study tests an artificial intelligence tool that uses ECG (a heart tracing) to spot likely blood sugar changes in people with type 1 diabetes. It may help improve earlier detection of “glycaemic events” without invasive testing.
This trial tests whether an AI system can detect signs of coronary artery disease (blockages in heart arteries) by analyzing a photo of your face. It may help identify people in the community who need further heart testing.
Hear when a new Pre Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.